Registered protocol
INPLASY2026110005
Protocol title
Resmetirom for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis of Phase 3 Evidence
Keywords
- Resmetirom
- metabolic dysfunction-associated steatotic liver disease
- metabolic dysfunction-associated steatohepatitis
- thyroid hormone receptor beta agonist
- LDL-cholesterol
Additional keywords may be available in the full-text protocol.
Registration timing
Retrospective
Review stage at registration
Data analysis